Piperazine,1-[4-[(2,3-dihydro-1-methyl-2-oxo-1H-imidazo[4,5-b]quinolin-7-yl)oxy]-1-oxobutyl]-4-(phenylmethyl)-, dihydrochloride

CAS No: 130289-19-9

130289-19-9

Order 130289-19-9

Order 1965-09-9 4,4'-Oxydiphenol

Order 34454-99-4 1,1,2,2,3,3,4,4,4-nonafluoro-N-2-hydroxyethyl-butane-1-sulfonamide

Order 56341-37-8 6-Chloro-2-Oxindole

Order 29654-55-5 3,5-Dihydroxybenzyl Alcohol

Order 534-85-0 2-Aminodiphenylamine

Order 2030-63-9 N,5-Bis(4-chlorophenyl)-3,5-dihydro-3-(isopropyliaino)phenazin-2-amine (Clofazimine)

Imidazo[

Order 766-55-2 Imidazo[1,2-b]pyridazine

Order 1313408-99-9 Ethyl 7-fluoroImidazo[1,2-a]pyridine-3-carboxylate

Order 99010-64-7 4-Chloro-1-(2-methylpropyl)-1H-Imidazo[4,5-c]quinoline

Order 877471-19-7 Imidazo[1,2-a]pyridine, 6-(2-furanyl)-

Order 258273-50-6 thylphenylacetic acid6-methyl-2-(4-methylphenyl)Imidazo[1,2-a]-pyridine-3-acetic acid

Order 877471-29-9 Imidazo[1,2-a]pyridin-6-ol, benzoate (ester)

Order 896739-32-5 3-Pyridinecarboxamide,6-chloro-N-[4-[2-(4-fluoro-3-methylphenyl)Imidazo[1,2-b]pyridazin-3-yl]-2-pyridinyl]-

Order 187235-13-8 (R)-2-NITRO-6,7-DIHYDRO-5H-Imidazo[2,1-B][1,3]OXAZIN-6-OL

Order 187235-08-1 (S)-2-NITRO-6,7-DIHYDRO-5H-Imidazo[2,1-B][1,3]OXAZIN-6-OL

Order 877471-25-5 Imidazo[1,2-a]pyridine, 6-(diethylboryl)-

Order 69-89-6 2,6-Dihydroxypurine

Order 668270-12-0 Linagliptin

Order 23761-23-1 3-Oxocyclobutanecarboxylic acid

Order 488-82-4 D-ARABINITOL

Order 251909-25-8 1-Ethyl-1-cyclohexyl acrylate

Order 60-92-4 Cyclic AMP

Order 6338-55-2 2-[2-(2-AMINOETHOXY)ETHOXY]ETHANOL

Order 145783-14-8 4,6-Dichloro-5-Nitro-2-Propylthiopyrimidine

130289-19-9 piperazine,dihydro,methyl,imidazo,quinolin,oxobutyl,phenylmethyl,dihydrochloride,imidazo[,piperazine,,130289-19-9

2025-12-03 Discover Piperazine,1-[4-[(2,3-dihydro-1-methyl-2-oxo-1H-imidazo[4,5-b]quinolin-7-yl)oxy]-1-oxobutyl]-4-(phenylmethyl)-, dihydrochloride (CAS No: 130289-19-9) and related compounds. Ideal for advanced chemical applications. Competitive pricing, fast delivery, and expert support worldwide.